2x222 42 6ReyesCK70倍，這也表明了腦病的嚴重程度。50%可以將心肌梗死和非梗死區分開來，總有效率為94%。磷酸肌酸+ 肌酸+HK,ATP+葡萄 ADP+葡萄糖-6-磷酸(G-6-G-6-P+ 6-+NADPH+1000.01?4.02.02.020?2.8302.00.210265.0() 檢查。對于AU2700/AU5400，應對所有環執行本步驟。在按照優良實驗室規范(GLP)進行定標之后，應立即進行質量控制程序。 <24U/L(0.4>>>>%(GLP)，測定自己的參考范圍。用于診斷時，應始終結合患者病史、臨床檢查和其它發現來評估結果。n=y=1.061x+r=n= 有關干擾物質詳情，請參閱Young9。 CK的影響，應通過電泳確認它的存在。 ¤分析儀默認 ThygesenK,AlpertJSetal.Myocardialinfarctionredefined-AconsensusdocumentoftheJointEuropeanSocietyofCardiology/AmericanCollegeofCardiologyCommitteefortheredefinitionofmyocardialinfarction.JACC2000;36:959-969.SteinW.Creatinekinase(totalactivity).Creatinekinaseisoenzymesandvariants.In:ThomasL,ed.Clinicallaboratorydiagnostics.Useandassessmentofclinicallaboratoryresults.Frankfurt/Main:TH-BooksVerlagsgesellschaft,5thed.1998:71-79./6thed.2005inGerman.MossDW,HendersonRA.Clinicalenzymology.In:BurtisCA,AshwoodER,eds.TietzTextbookofClinicalChemistry.Philadelphia:WBSaundersCompany,1999;657-662.WürzburgU,HennrichN,LangH.BestimmungderAktivit?tvonKreatinkinaseMBimSerumunterVerwendunginhibierenderAntik?rper.KlinWschr1976;54:357-360.FerardF,FranckPFH,GellaF-Jetal.IFCCPrimaryReferenceProceduresfortheMeasurementofCatalyticActivityConcentrationsofEnzymesat37°C.ClinChemLabMed2002;40:635-42.HorderM,ElserR,GerhardtW,MathieuM,SampsonE.J.InternationalFederationofClinicalChemistry,Scientificdivisioncommitteeonenzymes:ApprovedrecommendationonIFCCmethodsforthemeasurementofcatalyticconcentrationofenzymes.Part7.IFCCmethodforcreatinekinase.AppendixA.EurJClinChemBiochem1991;29(7):435-56.GuderWG,NarayananS,WisserH,ZawtaB.TheQualityofDiagnosticSamplesin:Samples:FromthePatienttotheLaboratory.Weinheim:Wiley-VCHVerlagGmbH&Co,KgaA,3rded.2003.KairistoV,H?nninenKP,LeinoA,PulkkiK,PeltolaO,N?nt?Vetal.Generationofreferencevaluesforcardiacenzymesfromhospitaladmissionlaboratorydata.EurJCli